WHITEHAWK THERAPEUTICS, INC. Operating Lease, Expense
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Operating Lease, Expense of $35.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. operating lease, expense for the quarter ending 2026-06-30 was $35.00K, a 2.94% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. operating lease, expense for the quarter ending 2026-03-31 was $11.00K, a 85.14% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. operating lease, expense for the quarter ending 2025-12-31 was -$68.00K, a 159.13% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. operating lease, expense for the quarter ending 2025-09-30 was $34.00K, a 70.43% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. operating lease, expense for fiscal 2025 was $74.00K, a 83.91% decline from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. operating lease, expense for fiscal 2024 was $460.00K, a 0.22% decline from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. operating lease, expense for fiscal 2023 was $461.00K, a 20.68% increase from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. operating lease, expense for fiscal 2022 was $382.00K, a 103.19% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $35.00K 10-Q · filed 2026-08-06 | $46.00K 10-Q · filed 2026-08-06 | -$22.00K derived: sum of 3 quarters · filed 2026-08-06 | $12.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $11.00K 10-Q · filed 2026-05-07 | -$57.00K derived: sum of 2 quarters · filed 2026-05-07 | -$23.00K derived: sum of 3 quarters · filed 2026-05-07 | $11.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$34.00K derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $74.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $34.00K 10-Q · filed 2025-11-06 | $68.00K derived: sum of 2 quarters · filed 2026-08-06 | $142.00K 10-Q · filed 2025-11-06 | $257.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $34.00K 10-Q · filed 2026-08-06 | $108.00K 10-Q · filed 2026-08-06 | $223.00K derived: sum of 3 quarters · filed 2026-08-06 | $338.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $74.00K 10-Q · filed 2026-05-07 | $189.00K derived: sum of 2 quarters · filed 2026-05-07 | $304.00K derived: sum of 3 quarters · filed 2026-05-07 | $419.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $230.00K derived: sum of 2 quarters · filed 2026-03-12 | $345.00K derived: sum of 3 quarters · filed 2026-03-12 | $460.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $115.00K 10-Q · filed 2025-11-06 | $230.00K derived: sum of 2 quarters · filed 2025-11-06 | $345.00K 10-Q · filed 2025-11-06 | $460.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $115.00K 10-Q · filed 2025-08-07 | $230.00K 10-Q · filed 2025-08-07 | $345.00K derived: sum of 3 quarters · filed 2025-08-07 | $460.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $115.00K 10-Q · filed 2025-05-08 | $230.00K derived: sum of 2 quarters · filed 2025-05-08 | $345.00K derived: sum of 3 quarters · filed 2025-05-08 | $460.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $230.00K derived: sum of 2 quarters · filed 2025-03-28 | $345.00K derived: sum of 3 quarters · filed 2025-03-28 | $461.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $115.00K 10-Q · filed 2024-11-06 | $230.00K derived: sum of 2 quarters · filed 2024-11-06 | $346.00K 10-Q · filed 2024-11-06 | $458.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $115.00K 10-Q · filed 2024-08-07 | $231.00K 10-Q · filed 2024-08-07 | $343.00K derived: sum of 3 quarters · filed 2024-08-07 | $455.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $116.00K 10-Q · filed 2024-05-08 | $228.00K derived: sum of 2 quarters · filed 2024-05-08 | $340.00K derived: sum of 3 quarters · filed 2024-05-08 | $447.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $224.00K derived: sum of 2 quarters · filed 2024-03-13 | $331.00K derived: sum of 3 quarters · filed 2024-03-13 | $382.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $112.00K 10-Q · filed 2023-11-08 | $219.00K derived: sum of 2 quarters · filed 2023-11-08 | $270.00K 10-Q · filed 2023-11-08 | $319.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $107.00K 10-Q · filed 2023-08-09 | $157.00K 10-Q · filed 2023-08-09 | $207.00K derived: sum of 3 quarters · filed 2023-08-09 | $254.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $50.00K 10-Q · filed 2023-05-10 | $100.00K derived: sum of 2 quarters · filed 2023-05-10 | $147.00K derived: sum of 3 quarters · filed 2023-05-10 | $193.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $97.00K derived: sum of 2 quarters · filed 2023-03-29 | $143.00K derived: sum of 3 quarters · filed 2023-03-29 | $188.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $47.00K 10-Q · filed 2022-11-09 | $93.00K derived: sum of 2 quarters · filed 2022-11-09 | $138.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $46.00K 10-Q · filed 2022-08-10 | $91.00K 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $46.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $183.00K 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |